-
INTEGRATING SOCIAL DETERMINANTS OF HEALTH INTO GLP-1 VALUE ASSESSMENT: A PROPOSED DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS FRAMEWORK
Mar 18, 2026, 21:38 PM -
USE ARTIFICIAL INTELLIGENCE TO PREDICT REGULATORY APPROVAL BASED ON PHASE III ONCOLOGY CLINICAL TRIAL PUBLICATIONS
Mar 18, 2026, 21:38 PM -
COST-UTILITY ANALYSIS OF SACITUZUMAB TIRUMOTECAN (SAC-TMT) IN PREVIOUSLY TREATED EGFR-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS: A CHINESE HEALTHCARE SYSTEM PERSPECTIVE
Mar 18, 2026, 21:38 PM -
TREATMENT COMPARISON FOR HTA. USING NICE AS AN EXAMPLE, DOES CURRENT USE REFLECT THE EVOLUTION FROM ANCHORED METHODS TO COMPLEX MODELS, AND ADJUSTMENT TECHNIQUES?
Mar 18, 2026, 21:38 PM -
REAL-WORLD ADHERENCE TO GLP-1RA AND DUAL GIP-GLP-1RA AMONG COMMERCIALLY INSURED US PATIENTS WITH TYPE 2 DIABETES AND OBESITY
Mar 18, 2026, 21:38 PM -
REDUCING DECISION UNCERTAINTY IN ULTRA-RARE PEDIATRIC CONDITIONS: A DELPHI-BASED APPROACH TO INFORM HTA AND PRICING & REIMBURSEMENT FOR NON-DYSTROPHIC MYOTONIAS
Mar 18, 2026, 21:38 PM -
CONCEPTUAL COST-EFFECTIVENESS FRAMEWORK FOR GMRX2 (TELMISARTAN/AMLODIPINE/INDAPAMIDE) AS EARLY COMBINATION THERAPY FOR US ADULTS WITH HYPERTENSION WITHOUT MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, USED EITHER AT INITIATION OR AS A STEP-UP FROM...
Mar 18, 2026, 21:38 PM -
RENEWAL PATHWAYS AND HEALTH INSURANCE COVERAGE RETENTION UNDER GHANA’S NHIS: IMPLICATIONS FOR UNIVERSAL HEALTH COVERAGE
Mar 18, 2026, 21:38 PM -
REAL-WORLD ROS1 TESTING IN FIRST-LINE NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
REAL-WORLD USE OF GENERATIVE AI ASSISTANT TOOLS ACROSS HEALTH ECONOMICS AND OUTCOMES RESEARCH WORKFLOWS: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
DOES ARTIFICIAL INTELLIGENCE IMPROVE OUTCOMES IN ACUTE ISCHEMIC STROKE CARE?
Mar 18, 2026, 21:38 PM -
CHANGES IN BREAST CANCER SCREENING PREVALENCE FOLLOWING UPDATED USPSTF MAMMOGRAPHY GUIDELINES: DESCRIPTIVE ANALYSIS USING MARKETSCAN TREATMENT PATHWAYS
Mar 18, 2026, 21:38 PM -
REPOSITIONING HEOR AS A RISK MITIGATION TOOL FOR HEALTHCARE INVESTMENT DECISION-MAKING: GOOD VALUE FOR MONEY?
Mar 18, 2026, 21:38 PM -
COST SAVINGS OF AN AI-ENABLED DIGITAL TWIN PROGRAM IN PREDIABETES AND HEALTHY WEIGHT MANAGEMENT
Mar 18, 2026, 21:38 PM -
HARNESSING AGENTIC AI FOR COHORT IDENTIFICATION: A CASE STUDY IN CLL/SLL PATIENTS TREATED WITH BTK INHIBITORS AT A US ACADEMIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
DEVELOPMENT AND VALIDATION OF A NOMOGRAM TO PREDICT OVERALL SURVIVAL IN NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF PHARMACIST-LED VIDEO TELEHEALTH MEDICATION THERAPY MANAGEMENT IN ADOLESCENTS AND YOUNG ADULTS WITH ASTHMA: A RANDOMIZED CONTROLLED TRIAL
Mar 18, 2026, 21:38 PM -
INDIVIDUAL PREFERENCES FOR UPPER EXTREMITY PROSTHETICS ALONG A USER-COMPLEXITY FRAMEWORK: A DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF DIABETES MANAGEMENT STRATEGIES: INSIGHTS FROM PATIENT GLUCOSE CONTROL TRAJECTORIESLITHUANIAN NATIONAL HEALTH INSURANCE FUND'S ADMINISTRATIVE DATA
Mar 18, 2026, 21:38 PM -
ARTIFICIAL INTELLIGENCE IN PHARMACOECONOMICS AND HEALTH ECONOMICS AND OUTCOME RESEARCH: A REVIEW OF APPLICATIONS AND CHALLENGES
Mar 18, 2026, 21:38 PM
